Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston
NEW YORK , January 15 /Businesswire/ - Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today it was awarded a provisional license from the Massachusetts Cannabis Control Commission for adult use retail sales at its medical marijuana dispensary, operated under Patriot Care, at 21 Milk Street in downtown Boston. In December, the Boston Zoning Board of Appeal approved a zoning permit that allows Patriot Care to expand its existing dispensary to include a co-located adult-use dispensary.
“This exciting news brings us one step closer to our goal of offering the same product quality and integrity to the adult use community that we provide to our medical patients. As the first co-located medical and adult-use dispensary in Boston, we are committed to establishing the benchmark of deep community engagement to help make our neighborhoods stronger and more vibrant. We are eager to get started and are grateful to those who have supported us along the way,” said Nicholas Vita, CEO of Columbia Care.
With this provisional license in place, Columbia Care will move toward final licensure and permission to commence operations.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions and the EU. Columbia Care currently operates 108 facilitiesi including 81 dispensaries and 27 cultivation and manufacturing facilities. Columbia Care is one of the original providers of medical cannabis in the United States, and continues to deliver an industry-leading, patient-centered medicinal cannabis operation that has quickly expanded into the adult use market as a premier operator. The company currently offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Amber and Platinum Label CBD. With more than four million sales transactions since its inception in 2012, Columbia Care is known for setting the standard for compassion, professionalism, quality, care, and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company's current expectations regarding future events. The Company has made assumptions with regard to the expansion of its Boston dispensary, which although considered reasonable by the Company at the time of preparation, may prove to be incorrect, as well as other risk factors discussed under "Risk Factors" in Columbia Care's Annual Information Form dated March 31, 2020, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.
_______________________
i Pro forma facilities either open or under development
View source version on businesswire.com: https://www.businesswire.com/news/home/20210115005111/en/
